Succinate dehydrogenase loss in familial paraganglioma: Biochemistry, genetics, and epigenetics

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Her, Yeng F ^a,b   Maher, L James ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 OXOGLUTARIC ACID; CHAPERONE; ISOCITRATE DEHYDROGENASE; PROTEIN FLX1; PROTEIN SDHAF1; PROTEIN SDHAF2; PROTEIN SDHAF3; PROTEIN SDHAF4; PROTEIN TCM62; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

BIOACCUMULATION; CANCER CELL; CANCER INCIDENCE; CARCINOGENESIS; CELL METABOLISM; CHONDROMA; CITRIC ACID CYCLE; COMPLEX II DEFICIENCY; ENZYME INHIBITION; ENZYME MODIFICATION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SYNTHESIS; EPITHELIAL MESENCHYMAL TRANSITION; GASTROINTESTINAL STROMAL TUMOR; GENE; GENE MUTATION; GENETIC ASSOCIATION; GLUCOSE METABOLISM; HUMAN; METABOLIC REGULATION; OXIDATIVE PHOSPHORYLATION; PARAGANGLIOMA; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN TARGETING; PULMONARY CHONDROMA; RESPIRATORY CHAIN; REVIEW; SDHA GENE; SDHAF2 GENE; SDHB GENE; SDHC GENE; SDHD GENE; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

EID: 84939131092     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/296167     Document Type: Review

References (144)

1. D. L. Nelson and M. M. Cox, Lehninger: Principles of Biochemistry, W. H. Freeman, NewYork, NY, USA, 4th edition, 2005.
2. O. Warburg, "Tests on surviving carcinoma cultures, " Biochemische Zeitschrift, vol. 142, pp. 317-333, 1923.
3. O. Warburg, "On the formation of lactic acid with growth, " Biochemische Zeitschrift, vol. 160, pp. 307-311, 1925.
4. M. A. Konerding, E. Fait, and A. Gaumann, "3D microvascular architecture of pre-cancerous lesions and invasive carcinomas of the colon, " British Journal of Cancer, vol. 84, no. 10, pp. 1354-1362, 2001.
5. R. A. Gatenby and R. J. Gillies, "Why do cancers have high aerobic glycolysis?" Nature Reviews Cancer, vol. 4, no. 11, pp. 891-899, 2004.
6. P. Carmeliet, Y. Dor, J. M. Herbert et al. , "Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis, " Nature, vol. 394, pp. 485-490, 1998.
7. J. A. Bertout, S. A. Patel, and M. C. Simon, "The impact of O2 availability on human cancer, " Nature Reviews Cancer, vol. 8, no. 12, pp. 967-975, 2008.
8. G. L. Semenza, "HIF-1: upstream and downstream of cancer metabolism, " Current Opinion in Genetics &Development, vol. 20, no. 1, pp. 51-56, 2010.
9. W. G. Kaelin Jr. and P. J. Ratcliffe, "Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway, " Molecular Cell, vol. 30, no. 4, pp. 393-402, 2008.
10. S. Gottschalk, N. Anderson, C. Hainz, S. G. Eckhardt, and N. J. Serkova, "Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells, " Clinical Cancer Research, vol. 10, no. 19, pp. 6661-6668, 2004.
11. R. L. Elstrom, D. E. Bauer, M. Buzzai et al. , "Akt stimulates aerobic glycolysis in cancer cells, " Cancer Research, vol. 64, no. 11, pp. 3892-3899, 2004.
12. K. B. Nolop, C. G. Rhodes, L. H. Brudin et al. , "Glucose utilization in vivo by human pulmonary neoplasms, " Cancer, vol. 60, no. 11, pp. 2682-2689, 1987.
13. M. G. V. Heiden, L. C. Cantley, and C. B. Thompson, "Understanding the warburg effect: the metabolic requirements of cell proliferation, " Science, vol. 324, no. 5930, pp. 1029-1033, 2009.
14. G. Hatzivassiliou, F. Zhao, D. E. Bauer et al. , "ATP citrate lyase inhibition can suppress tumor cell growth, " Cancer Cell, vol. 8, no. 4, pp. 311-321, 2005.
15. V. R. Fantin, J. St-Pierre, and P. Leder, "Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance, " Cancer Cell, vol. 9, no. 6, pp. 425-434, 2006.
16. T. Fiaschi, A. Marini, E. Giannoni et al. , "Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay, " Cancer Research, vol. 72, no. 19, pp. 5130-5140, 2012.
17. E. Rapizzi, R. Fucci, E. Giannoni et al. , "Role of microenvironment on neuroblastoma SK-N-AS SDHB-silenced cell metabolism and function, " Endocrine Related Cancer, vol. 22, no. 3, pp. 409-417, 2015.
18. C. Hägerhäll, "Succinate: quinone oxidoreductases: variations on a conserved theme, " Biochimica et Biophysica Acta: Bioenergetics, vol. 1320, no. 2, pp. 107-141, 1997.
19. V. Yankovskaya, R. Horsefield, S. Törnroth et al. , "Architecture of succinate dehydrogenase and reactive oxygen species generation, " Science, vol. 299, no. 5607, pp. 700-704, 2003.
20. F. Sun, X. Huo, Y. Zhai et al. , "Crystal structure ofmitochondrial respiratory membrane protein complex II, " Cell, vol. 121, no. 7, pp. 1043-1057, 2005.
21. K. S. Oyedotun, C. S. Sit, and B. D. Lemire, "The Saccharomyces cerevisiae succinate dehydrogenase does not require heme for ubiquinone reduction, " Biochimica et Biophysica Acta: Bioenergetics, vol. 1767, no. 12, pp. 1436-1445, 2007.
22. Y. Silkin, K. S. Oyedotun, and B. D. Lemire, "The role of Sdh4p Tyr-89 in ubiquinone reduction by the Saccharomyces cerevisiae succinate dehydrogenase, " Biochimica et Biophysica Acta-Bioenergetics, vol. 1767, no. 2, pp. 143-150, 2007.
23. T. A. Alston, L. Mela, and H. J. Bright, "3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase, " Proceedings of theNationalAcademy of Sciences of theUnited States of America, vol. 74, no. 9, pp. 3767-3771, 1977.
24. M. Gutman and N. Silman, "The steady state activity of succinate dehydrogenase in the presence of opposing effectors. II. Reductive activation of succinate dehydrogenase in presence of oxaloacetate, "Molecular and Cellular Biochemistry, vol. 7, no. 3, pp. 177-185, 1975.
25. P. Gunasekaran and P. Tauro, "Mechanism of action of carboxin and the development of resistance in yeast, " Journal of Biosciences, vol. 4, no. 2, pp. 219-225, 1982.
26. M. Chauveau and J. Roussaux, "EPR studies on 6-benzoylaminopurine and thenoyltrifluoroacetone inhibition sites of succinate dehydrogenase in plant mitochondria, " Plant and Cell Physiology, vol. 37, no. 7, pp. 914-921, 1996.
27. E. Tomitsuka, K. Kita, and H. Esumi, "Regulation of succinateubiquinone reductase and fumarate reductase activities in human complex II by phosphorylation of its flavoprotein subunit, " Proceedings of the Japan Academy-Series B: Physical and Biological Sciences, vol. 85, no. 7, pp. 258-265, 2009.
28. H. Cimen, M. -J. Han, Y. Yang, Q. Tong, H. Koc, and E. C. Koc, "Regulation of succinate dehydrogenase activity by SIRT3 in mammalian mitochondria, " Biochemistry, vol. 49, no. 2, pp. 304-311, 2010.
29. J. Park, Y. Chen, D. X. Tishkoff et al. , "SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways, " Molecular Cell, vol. 50, no. 6, pp. 919-930, 2013.
30. B. T. Weinert, C. Schölz, S. A. Wagner et al. , "Lysine succinylation is a frequently occurring modification in prokaryotes and eukaryotes and extensively overlaps with acetylation, " Cell Reports, vol. 4, no. 4, pp. 842-851, 2013.
31. E. Dibrov, S. Fu, and B. D. Lemire, "The Saccharomyces cerevisiae TCM62 gene encodes a chaperone necessary for the assembly of the mitochondrial succinate dehydrogenase (complex II), " The Journal of Biological Chemistry, vol. 273, pp. 32042-32048, 1998.
32. C. Klanner, W. Neupert, and T. Langer, "The chaperonin-related protein Tcm62p ensures mitochondrial gene expresssion under heat stress, " FEBS Letters, vol. 470, no. 3, pp. 365-369, 2000.
33. M. G. V. Heiden, J. S. Choy, D. J. VanderWeele et al. , "Bcl-xL complements Saccharomyces cerevisiae genes that facilitate the switch from glycolytic to oxidative metabolism, " The Journal of Biological Chemistry, vol. 277, no. 47, pp. 44870-44876, 2002.
34. A. J. Robinson and E. R. S. Kunji, "Mitochondrial carriers in the cytoplasmic state have a common substrate binding site, " Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2617-2622, 2006.
35. A. Tzagoloff, J. Jang, D. M. Glerum, and M. Wu, "FLX1 codes for a carrier protein involved in maintaining a proper balance of flavin nucleotides in yeast mitochondria, " The Journal of Biological Chemistry, vol. 271, no. 13, pp. 7392-7397, 1996.
36. H. -X. Hao, O. Khalimonchuk, M. Schraders et al. , "SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma, " Science, vol. 325, no. 5944, pp. 1139-1142, 2009.
37. T. A. Giancaspero, E. Dipalo, A. Miccolis, E. Boles, M. Caselle, and M. Barile, "Alteration of ROS homeostasis and decreased lifespan in S. cerevisiae elicited by deletion of themitochondrial translocator FLX1, " BioMed Research International, vol. 2014, Article ID 101286, 12 pages, 2014.
38. D. Ghezzi, P. Goffrini, G. Uziel et al. , "SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDHdefective infantile leukoencephalopathy, " Nature Genetics, vol. 41, no. 6, pp. 654-656, 2009.
39. M. Bugiani, E. Lamantea, F. Invernizzi et al. , "Effects of riboflavin in children with complex II deficiency, " Brain & Development, vol. 28, no. 9, pp. 576-581, 2006.
40. U. Na, W. Yu, J. Cox et al. , "TheLYR factors sdhaf1 and SDHAF3 mediate maturation of the iron-sulfur subunit of succinate dehydrogenase, " Cell Metabolism, vol. 20, no. 2, pp. 253-266, 2014.
41. H. J. Kim, M. -Y. Jeong, U. Na, and D. R. Winge, "Flavinylation and assembly of succinate dehydrogenase are dependent on the C-terminal tail of the flavoprotein subunit, " The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40670-40679, 2012.
42. L. Zafreen, L. Huang, N. Walker-Kopp, and E. A. Berry, "The role of SDH assembly factor 2 and YgfY in flavinylation of succinate dehydrogenase flavoprotein, " Biophysical Journal, vol. 104, no. 2, supplement 1, p. 46a, 2013.
43. S. Huang, N. L. Taylor, E. Ströher, R. Fenske, and A. H. Millar, "Succinate dehydrogenase assembly factor 2 is needed for assembly and activity of mitochondrial complex II and for normal root elongation in Arabidopsis, " The Plant Journal, vol. 73, no. 3, pp. 429-441, 2013.
44. J. G. van Vranken, D. K. Bricker, N. Dephoure et al. , "SDHAF4 promotes mitochondrial Succinate dehydrogenase activity and prevents neurodegeneration, " CellMetabolism, vol. 20, no. 2, pp. 241-252, 2014.
45. C. M. Beard, S. G. Sheps, L. T. Kurland, J. A. Carney, and J. T. Lie, "Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979, " Mayo Clinic Proceedings, vol. 58, no. 12, pp. 802-804, 1983.
46. J. Welander, P. Söderkvist, and O. Gimm, "Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas, " Endocrine-Related Cancer, vol. 18, no. 6, pp. R253-R276, 2011.
47. N. van Duinen, D. Steenvoorden, I. P. Kema et al. , "Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas, "The Journal of Clinical Endocrinology &Metabolism, vol. 95, no. 1, pp. 209-214, 2010.
48. A. M. McNicol, "Update on tumours of the adrenal cortex, phaeochromocytoma and extra-adrenal paraganglioma, " Histopathology, vol. 58, no. 2, pp. 155-168, 2011.
49. D. Erickson, Y. C. Kudva, M. J. Ebersold et al. , "Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients, " The Journal of Clinical Endocrinology &Metabolism, vol. 86, no. 11, pp. 5210-5216, 2001.
50. J. A. Lee and Q. -Y. Duh, "Sporadic paraganglioma, " World Journal of Surgery, vol. 32, no. 5, pp. 683-687, 2008.
51. H. Dannenberg, W. N. M. Dinjens, M. Abbou et al. , "Frequent germ-line succinate dehydrogenase subunit D gene mutations in patients with apparently sporadic parasympathetic paraganglioma, " Clinical Cancer Research, vol. 8, no. 7, pp. 2061-2066, 2002.
52. B. Ramlawi, E. A. David, M. P. Kim et al. , "Contemporary surgical management of cardiac paragangliomas, " The Annals of Thoracic Surgery, vol. 93, no. 6, pp. 1972-1976, 2012.
53. M. L. Brown, G. E. Zayas, M. D. Abel, W. F. Young Jr. , and H. V. Schaff, "Mediastinal paragangliomas: the mayo clinic experience, " The Annals of Thoracic Surgery, vol. 86, no. 3, pp. 946-951, 2008.
54. L. N. Simpson, B. D. Hughes, I. O. Karikari et al. , "Catecholamine-secreting paraganglioma of the thoracic spinal column: report of an unusual case and review of the literature, " Neurosurgery, vol. 70, no. 4, pp. E1049-E1052, 2012.
55. M. Al-Harthy, S. Al-Harthy, A. Al-Otieschan, S. Velagapudi, and A. S. Alzahrani, "Comparison of pheochromocytomas and abdominal and pelvic paragangliomas with head and neck paragangliomas, " Endocrine Practice, vol. 15, no. 3, pp. 194-202, 2009.
56. M. J. Saldana, L. E. Salem, and R. Travezan, "High altitude hypoxia and chemodectomas, " Human Pathology, vol. 4, no. 2, pp. 251-263, 1973.
57. Q. Khan, D. Heath, P. Smith, and T. Norboo, "The histology of the carotid bodies in highlanders from Ladakh, " International Journal of Biometeorology, vol. 32, no. 4, pp. 254-259, 1988.
58. S. Rodríguez-Cuevas, J. López-Garza, and S. Labastida-Almendaro, "Carotid body tumors in inhabitants of altitudes higher than 2000 meters above sea level, " Head &Neck, vol. 20, no. 5, pp. 374-378, 1998.
59. J. Arias-Stella and F. Bustos, "Chronic hypoxia and chemodectomas in bovines at high altitudes, " Archives of Pathology & Laboratory Medicine, vol. 100, no. 12, pp. 636-639, 1976.
60. A. R. Opotowsky, L. E. Moko, J. Ginns et al. , "Pheochromocytoma and paraganglioma in cyanotic congenital heart disease, " TheJournal of Clinical Endocrinology&Metabolism, vol. 100, no. 4, pp. 1325-1334, 2015.
61. G. M. Folger Jr. , W. C. Roberts, A. Mehrizi et al. , "Cyanotic malformations of the heart with pheochromocytoma. A report of five cases, " Circulation, vol. 29, pp. 750-757, 1964.
62. T. Kita, T. Imamura, H. Date et al. , "Two cases of pheochromocytoma associated with tetralogy of fallot, " Hypertension Research, vol. 26, no. 5, pp. 433-437, 2003.
63. L. Fishbein, S. Merrill, D. L. Fraker, D. L. Cohen, and K. L. Nathanson, "Inherited mutations in pheochromocytoma and paraganglioma: why all patients should be offered genetic testing, "TheAnnals of SurgicalOncology, vol. 20, no. 5, pp. 1444-1450, 2013.
64. C. Bardella, P. J. Pollard, and I. Tomlinson, "SDHmutations in cancer, " Biochimica et Biophysica Acta: Bioenergetics, vol. 1807, no. 11, pp. 1432-1443, 2011.
65. P. L. M. Dahia, "Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity, " Nature Reviews Cancer, vol. 14, no. 2, pp. 108-119, 2014.
66. J. Favier, L. Amar, and A. -P. Gimenez-Roqueplo, "Paraganglioma and phaeochromocytoma: from genetics to personalized medicine, " Nature Reviews Endocrinology, vol. 11, no. 2, pp. 101-111, 2015.
67. L. J. Castro-Vega, C. Lepoutre-Lussey, A. P. Gimenez-Roqueplo, and J. Favier, "Rethinking pheochromocytomas and paragangliomas from a genomic perspective, " Oncogene, 2015.
68. A. Cascon, I. Comino-Mendez, M. Curras-Freixes et al. , "Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene, " Journal of the National Cancer Institute, vol. 107, no. 5, p. djv053, 2015.
69. E. Korpershoek, J. Favier, J. Gaal et al. , "SDHA immunohistochemistry detects germline SDHAgenemutations in apparently sporadic paragangliomas and pheochromocytomas, " The Journal of Clinical Endocrinology &Metabolism, vol. 96, no. 9, pp. E1472-E1476, 2011.
70. N. Burnichon, J. -J. Brière, R. Libé et al. , "SDHA is a tumor suppressor gene causing paraganglioma, " Human Molecular Genetics, vol. 19, no. 15, pp. 3011-3020, 2010.
71. T. Bourgeron, P. Rustin, D. Chretien et al. , "Mutation of a nuclear succinate dehydrogenase gene results in mitochondrial respiratory chain deficiency, " Nature Genetics, vol. 11, no. 2, pp. 144-149, 1995.
72. B. Parfait, D. Chretien, A. Rötig, C. Marsac, A. Munnich, and P. Rustin, "Compound heterozygousmutations in the flavoprotein gene of the respiratory chain complex II in a patient with Leigh syndrome, " Human Genetics, vol. 106, no. 2, pp. 236-243, 2000.
73. R. Horváth, A. Abicht, E. Holinski-Feder et al. , "Leigh syndrome caused by mutations in the flavoprotein (Fp) subunit of succinate dehydrogenase (SDHA), " Journal of Neurology, Neurosurgery and Psychiatry, vol. 77, no. 1, pp. 74-76, 2006.
74. D. Astuti, F. Latif, A. Dallol et al. , "Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma, " American Journal of Human Genetics, vol. 69, no. 1, pp. 49-54, 2001.
75. A. -P. Gimenez-Roqueplo, J. Favier, P. Rustin et al. , "Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas, " Cancer Research, vol. 63, no. 17, pp. 5615-5621, 2003.
76. A. -P. Gimenez-Roqueplo, J. Favier, P. Rustin et al. , "Functional consequences of a SDHB gene mutation in an apparently sporadic pheochromocytoma, " Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 10, pp. 4771-4774, 2002.
77. H. P. H. Neumann, C. Pawlu, M. Pęczkowska et al. , "Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD and genemutations, " Journal of the American Medical Association, vol. 292, no. 8, pp. 943-951, 2004.
78. C. J. Ricketts, J. R. Forman, E. Rattenberry et al. , "Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD, " Human Mutation, vol. 31, no. 1, pp. 41-51, 2010.
79. S. Vanharanta, M. Buchta, S. R. McWhinney et al. , "Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma, " American Journal of Human Genetics, vol. 74, no. 1, pp. 153-159, 2004.
80. S. Niemann and U. Muller, "Mutations in SDHC cause autosomal dominant paraganglioma, type 3, " Nature Genetics, vol. 26, no. 3, pp. 268-270, 2000.
81. M. Mannelli, T. Ercolino, V. Giachè, L. Simi, C. Cirami, and G. Parenti, "Genetic screening for pheochromocytoma: should SDHC gene analysis be included?" Journal of Medical Genetics, vol. 44, no. 9, pp. 586-587, 2007.
82. F. Schiavi, C. C. Boedeker, B. Bausch et al. , "Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene, " Journal of the American Medical Association, vol. 294, no. 16, pp. 2057-2063, 2005.
83. B. E. Baysal, J. E. Willett-Brozick, E. C. Lawrence et al. , "Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas, " Journal of Medical Genetics, vol. 39, no. 3, pp. 178-183, 2002.
84. T. Ishii, K. Yasuda, A. Akatsuka, O. Hino, P. S. Hartman, and N. Ishii, "A mutation in the SDHC gene of complex II increases oxidative stress, resulting in apoptosis and tumorigenesis, " Cancer Research, vol. 65, no. 1, pp. 203-209, 2005.
85. B. E. Baysal, R. E. Ferrell, J. E. Willett-Brozick et al. , "Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma, " Science, vol. 287, no. 5454, pp. 848-851, 2000.
86. B. Pasini and C. A. Stratakis, "SDH mutations in tumorigenesis and inherited endocrine tumours: lesson from the phaeochromocytoma-paraganglioma syndromes, " Journal of Internal Medicine, vol. 266, no. 1, pp. 19-42, 2009.
87. E. F. Hensen, M. D. Siemers, J. C. Jansen et al. , "Mutations in SDHD are the major determinants of the clinical characteristics of Dutch head and neck paraganglioma patients, " Clinical Endocrinology, vol. 75, no. 5, pp. 650-655, 2011.
88. C. Jiménez, G. Cote, A. Arnold, and R. F. Gagel, "Should patients with apparently sporadic pheochromocytomas or paragangliomas be screened for hereditary syndromes?" Journal of Clinical Endocrinology and Metabolism, vol. 91, no. 8, pp. 2851-2858, 2006.
89. H. P. M. Kunst, M. H. Rutten, J. -P. deMönnink et al. , "SDHAF2 (PGL2-SDH5) and hereditary head and neck paraganglioma, " Clinical Cancer Research, vol. 17, no. 2, pp. 247-254, 2011.
90. M. Miettinen, Z. -F. Wang, M. Sarlomo-Rikala, C. Osuch, P. Rutkowski, and J. Lasota, "Succinate dehydrogenase-deficient GISTs: a clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastricGISTswith predilection to young age, " American Journal of Surgical Pathology, vol. 35, no. 11, pp. 1712-1721, 2011.
91. L. Zhang, T. C. Smyrk, W. F. Young, C. A. Stratakis, and J. A. Carney, "Gastric stromal tumors in carney triad are different clinically, pathologically, and behaviorally fromsporadic gastric gastrointestinal stromal tumors: findings in 104 cases, " American Journal of Surgical Pathology, vol. 34, no. 1, pp. 53-64, 2010.
92. K. A. Janeway, S. Y. Kim, M. Lodish et al. , "Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations, " Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 1, pp. 314-318, 2011.
93. M. Miettinen and J. Lasota, "Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs)-a review, " The International Journal of Biochemistry &Cell Biology, vol. 53, pp. 514-519, 2014.
94. M. Miettinen, J. K. Killian, Z. -F. Wang et al. , "Immunohistochemical loss of succinate dehydrogenase subunit a (SDHA) in gastrointestinal stromal tumors (GISTs) signals SDHAgermline mutation, "American Journal of Surgical Pathology, vol. 37, no. 2, pp. 234-240, 2013.
95. B. Pasini, S. R. McWhinney, T. Bei et al. , "Clinical andmolecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD, " European Journal of Human Genetics, vol. 16, no. 1, pp. 79-88, 2008.
96. S. R. McWhinney, B. Pasini, and C. A. Stratakis, "Familial gastrointestinal stromal tumors and germ-line mutations, " The New England Journal ofMedicine, vol. 357, no. 10, pp. 1054-1056, 2007.
97. C. A. Stratakis and J. A. Carney, "The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome):molecular genetics and clinical implications, " Journal of Internal Medicine, vol. 266, no. 1, pp. 43-52, 2009.
98. J. K. Killian, S. Y. Kim, M. Miettinen et al. , "Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor, " Cancer Discovery, vol. 3, no. 6, pp. 648-657, 2013.
99. F. Haller, E. A. Moskalev, F. R. Faucz et al. , "Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad, " Endocrine-Related Cancer, vol. 21, no. 4, pp. 567-577, 2014.
100. M. P. Murphy, "How mitochondria produce reactive oxygen species, " Biochemical Journal, vol. 417, no. 1, pp. 1-13, 2009.
101. S. Raha, G. E. McEachern, A. T. Myint, and B. H. Robinson, "Superoxides from mitochondrial complex III: the role of manganese superoxide dismutase, " Free Radical Biology and Medicine, vol. 29, no. 2, pp. 170-180, 2000.
102. H. Adachi, Y. Fujiwara, and N. Ishii, "Effects of oxygen on protein carbonyl and aging in Caenorhabditis elegans mutants with long (age-1) and short (mev-1) life spans, " Journals of Gerontology A: Biological Sciences and Medical Sciences, vol. 53, no. 4, pp. B240-B244, 1998.
103. J. Guo and B. D. Lemire, "The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide, "The Journal of Biological Chemistry, vol. 278, no. 48, pp. 47629-47635, 2003.
104. N. Senoo-Matsuda, K. Yasuda, M. Tsuda et al. , "A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans, " The Journal of Biological Chemistry, vol. 276, no. 45, pp. 41553-41558, 2001.
105. B. G. Slane, N. Aykin-Burns, B. J. Smith et al. , "Mutation of succinate dehydrogenase subunit C results in increased O2. -, oxidative stress, and genomic instability, " Cancer Research, vol. 66, no. 15, pp. 7615-7620, 2006.
106. E. H. Smith, R. Janknecht, and J. L. Maher III, "Succinate inhibition of α-ketoglutarate-dependent enzymes in a yeast model of paraganglioma, " Human Molecular Genetics, vol. 16, no. 24, pp. 3136-3148, 2007.
107. P. Goffrini, T. Ercolino, E. Panizza et al. , "Functional study in a yeast model of a novel succinate dehydrogenase subunit B gene germline missense mutation (C191Y) diagnosed in a patient affected by a glomus tumor, " HumanMolecular Genetics, vol. 18, no. 10, pp. 1860-1868, 2009.
108. S. S. W. Szeto, S. N. Reinke, B. D. Sykes, and B. D. Lemire, "Ubiquinone-binding sitemutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate, " The Journal of Biological Chemistry, vol. 282, no. 37, pp. 27518-27526, 2007.
109. M. A. Selak, S. M. Armour, E. D. MacKenzie et al. , "Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase, " Cancer Cell, vol. 7, no. 1, pp. 77-85, 2005.
110. M. A. Selak, R. V. Durán, and E. Gottlieb, "Redox stress is not essential for the pseudo-hypoxic phenotype of succinate dehydrogenase deficient cells, " Biochimica et Biophysica Acta, vol. 1757, no. 5-6, pp. 567-572, 2006.
111. J. -J. Brière, J. Favier, P. Bénit et al. , "Mitochondrial succinate is instrumental for HIF1α nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions, " Human Molecular Genetics, vol. 14, no. 21, pp. 3263-3269, 2005.
112. R. D. Guzy, B. Sharma, E. Bell, N. S. Chandel, and P. T. Schumacker, "Loss of the SdhB, but not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxiainducible factor activation and tumorigenesis, " Molecular and Cellular Biology, vol. 28, no. 2, pp. 718-731, 2008.
113. R. Myllyla, L. Tuderman, and K. I. Kivirikko, "Mechanism of the prolyl hydroxylase reaction. 2. Kinetic analysis of the reaction sequence, " European Journal of Biochemistry, vol. 80, no. 2, pp. 349-357, 1977.
114. L. Tuderman, R. Myllylä, and K. Kivirikko, "Mechanism of the prolyl hydroxylase reaction. 1. Role of co-substrates, " European Journal of Biochemistry, vol. 80, no. 2, pp. 341-348, 1977.
115. E. D. MacKenzie, M. A. Selak, D. A. Tennant et al. , "Cellpermeating α-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells, " Molecular and Cellular Biology, vol. 27, no. 9, pp. 3282-3289, 2007.
116. A. M. Cervera, N. Apostolova, F. L. Crespo, M. Mata, and K. J. McCreath, "Cells silenced for SDHB expression display characteristic features of the tumor phenotype, " Cancer Research, vol. 68, no. 11, pp. 4058-4067, 2008.
117. A. M. Cervera, J. -P. Bayley, P. Devilee, and K. J. McCreath, "Inhibition of succinate dehydrogenase dysregulates histone modification in mammalian cells, " Molecular Cancer, vol. 8, article 89, 2009.
118. M. Xiao, H. Yang, W. Xu et al. , "Inhibition of α-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors, " Genes &Development, vol. 26, no. 12, pp. 1326-1338, 2012.
119. E. Letouzé, C. Martinelli, C. Loriot et al. , "SDHmutations establish a hypermethylator phenotype in paraganglioma, " Cancer Cell, vol. 23, no. 6, pp. 739-752, 2013.
120. A. -P. Gimenez-Roqueplo, J. Favier, P. Rustin et al. , "The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway, " The American Journal of Human Genetics, vol. 69, no. 6, pp. 1186-1197, 2001.
121. P. J. Pollard, J. J. Brière, N. A. Alamet al. , "Accumulation ofKrebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations, " Human Molecular Genetics, vol. 14, no. 15, pp. 2231-2239, 2005.
122. P. L. M. Dahia, K. N. Ross, M. E. Wright et al. , "A HIf1α regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas, " PLoS Genetics, vol. 1, no. 1, pp. 72-80, 2005.
123. E. López-Jiménez, G. Gómez-López, L. J. Leandro-García et al. , "Research resource: transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas, " Molecular Endocrinology, vol. 24, no. 12, pp. 2382-2391, 2010.
124. J. Favier, J. -J. Brière, N. Burnichon et al. , "The warburg effect is genetically determined in inherited pheochromocytomas, " PLoS ONE, vol. 4, no. 9, Article ID e7094, 2009.
125. Y. F. Her, M. Nelson-Holte, and L. J. Maher III, "Oxygen concentration controls epigenetic effects in models of familial paraganglioma, " PLoS ONE, vol. 10, no. 2, Article ID e0127471, 2015.
126. W. G. Kaelin Jr. , "Cancer and altered metabolism: potential importance of hypoxia-Inducible factor and 2-oxoglutaratedependent dioxygenases, " Cold Spring Harbor Symposia on Quantitative Biology, vol. 76, pp. 335-345, 2011.
127. W. G. Kaelin, "IDH mutations, 2-oxoglutarate-dependent dioxygenases, and leukemia, " Blood, vol. 124, no. 21, p. SCI-6, 2014.
128. R. P. Hausinger, "FeII/alpha-ketoglutarate-dependent hydroxylases and related enzymes, " Critical Reviews in Biochemistry and Molecular Biology, vol. 39, pp. 21-68, 2004.
129. G. Zheng, J. A. Dahl, Y. Niuet al. , "ALKBH5is a aammalianRNA demethylase that impactsRNAmetabolism andmouse fertility, " Molecular Cell, vol. 49, no. 1, pp. 18-29, 2013.
130. X. Wang, Z. Lu, A. Gomez et al. , "N 6-methyladenosinedependent regulation of messenger RNA stability, " Nature, vol. 505, no. 7481, pp. 117-120, 2014.
131. O. Sundheim, V. A. Talstad, C. B. Vågbo, G. Slupphaug, and H. E. Krokan, "AlkB demethylases flip out in different ways, " DNA Repair, vol. 7, no. 11, pp. 1916-1923, 2008.
132. B. V. Geisbrecht and S. J. Gould, "The human PICD gene encodes a cytoplasmic and peroxisomal NADP+-dependent isocitrate dehydrogenase, " The Journal of Biological Chemistry, vol. 274, no. 43, pp. 30527-30533, 1999.
133. L. Dang, D. W. White, S. Gross et al. , "Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, " Nature, vol. 462, no. 7274, pp. 739-744, 2009.
134. P. S. Ward, J. Patel, D. R. Wise et al. , "The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting α-ketoglutarate to 2-hydroxyglutarate, " Cancer Cell, vol. 17, no. 3, pp. 225-234, 2010.
135. Z. Turkalp, J. Karamchandani, and S. Das, "IDH mutation in glioma: new insights and promises for the future, " JAMA Neurology, vol. 71, no. 10, pp. 1319-1325, 2014.
136. W. Xu, H. Yang, Y. Liu et al. , "Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases, " Cancer Cell, vol. 19, no. 1, pp. 17-30, 2011.
137. R. Chowdhury, K. K. Yeoh, Y. -M. Tian et al. , "The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases, " EMBO Reports, vol. 12, no. 5, pp. 463-469, 2011.
138. L. Dang, S. Jin, and S. M. Su, "IDH mutations in glioma and acute myeloid leukemia, " Trends in Molecular Medicine, vol. 16, no. 9, pp. 387-397, 2010.
139. N. A. Alam, A. J. Rowan, N. C. Wortham et al. , "Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency, " Human Molecular Genetics, vol. 12, no. 11, pp. 1241-1252, 2003.
140. L. J. Castro-Vega, A. Buffet, A. A. De Cubas et al. , "Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas, " Human Molecular Genetics, vol. 23, no. 9, Article ID ddt639, pp. 2440-2446, 2014.
141. P. Koivunen, M. Hirsilä, A. M. Remes, I. E. Hassinen, K. I. Kivirikko, and J. Myllyharju, "Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF, " The Journal of Biological Chemistry, vol. 282, no. 7, pp. 4524-4532, 2007.
142. K. S. Hewitson, B. M. R. Liénard, M. A. McDonough et al. , "Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates, " The Journal of Biological Chemistry, vol. 282, no. 5, pp. 3293-3301, 2007.
143. H. Lu, C. L. Dalgard, A. Mohyeldin, T. McFate, A. S. Tait, and A. Verma, "Reversible inactivation ofHIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1, " The Journal of Biological Chemistry, vol. 280, no. 51, pp. 41928-41939, 2005.
144. J. S. Isaacs, Y. J. Yun, D. R. Mole et al. , "HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability, " Cancer Cell, vol. 8, no. 2, pp. 143-153, 2005.